p44/42(ERK1/2) MAPK and PLD activation by PGD2 preserves papillary phosphatidylcholine homeostasis

Biochemical and Biophysical Research Communications
María Fernández-TomeNorma Sterin-Speziale

Abstract

Previous works from our laboratory demonstrated that PGD(2) modulates phosphatidylcholine (PC) biosynthesis in renal papillary tissue. In the present work, we have evaluated the mechanism by which PGD(2) exerts this action. PGD(2) caused two stimulatory waves in PC synthesis which were reproduced by its full-agonist BW245C. At 1min stimulation, PGD(2) increased PC synthesis by 131%; this increase was blocked by neomycin and ethanol, cheleritrine and U0126, PLD, PKC, and MEK1/2 inhibitors, respectively. A second PC synthesis increase (100%) was observed after 15min, which was blocked by PLD inhibitors. PGD(2) also increased phospho-ERK1/2 MAPK in a biphasic-fashion, which was abolished by PLC and PKC inhibitors but not by ethanol, which overincreased phospho-ERK1/2, suggesting that PGD(2)-induced ERK1/2 activation requires previous PLC-PKC activation while PLD down-regulates it. Our results indicate that PGD(2) stimulatory effect involves both PLD and ERK1/2-MAPK activation, and both pathways operate independently of PC synthesis homeostasis.

References

Jan 1, 1992·Lipids·N Sterin-SpezialeE H Speziale
Jan 1, 1996·Kidney & Blood Pressure Research·C P Setton-AvrujN B Sterin-Speziale
Jan 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S GhoshR M Bell
Nov 5, 1997·Analytical Biochemistry·A J MorrisJ Engebrecht
Jan 8, 1998·Biochimica Et Biophysica Acta·M C Fernández-ToméN B Sterin-Speziale
Jan 15, 1999·Clinical and Experimental Pharmacology & Physiology·C A Kanashiro, R A Khalil
Mar 27, 1999·The Journal of Biological Chemistry·I Baburina, S Jackowski
Jul 9, 1999·Biochimica Et Biophysica Acta·S E BarbourC L Deal
Jan 25, 2000·American Journal of Physiology. Cell Physiology·S ZhuangS Ohno
May 4, 2000·Progress in Lipid Research·A M MartelliL M Neri
Sep 29, 2000·Progress in Nucleic Acid Research and Molecular Biology·A Lykidis, S Jackowski
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·R M BreyerM D Breyer
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Dec 31, 2003·Biochemical Pharmacology·María Fernández-TomeNorma Sterin-Speziale

❮ Previous
Next ❯

Citations

Dec 28, 2012·Journal of Lipid Research·Cecilia I CasaliMaría C Fernández Tome
Jul 1, 2014·European Journal of Pharmacology·Shigeyoshi HonmaMakoto Yoshida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.